(Q45361755)

13 December 2017

title

Plasma Epstein-Barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma (English)

1 reference

13 December 2017

0 references

7

Chun-Ta Liao

1 reference

13 December 2017

Cheng-Lung Hsu

1

1 reference

13 December 2017

Kai-Ping Chang

2

1 reference

13 December 2017

Chien-Yu Lin

3

1 reference

13 December 2017

Hsien-Kun Chang

4

1 reference

13 December 2017

Cheng-Hsu Wang

5

1 reference

13 December 2017

Tung-Liang Lin

6

1 reference

13 December 2017

Ngan-Ming Tsang

8

1 reference

13 December 2017

Li-Yu Lee

9

1 reference

13 December 2017

Sheng-Chieh Chan

10

1 reference

13 December 2017

Shu-Hang Ng

11

1 reference

13 December 2017

Hsin-Pai Li

12

1 reference

13 December 2017

Yu-Sun Chang

13

1 reference

13 December 2017

Hung-Ming Wang

14

1 reference

13 December 2017

publication date

15 November 2011

1 reference

13 December 2017

1 reference

13 December 2017

volume

34

1 reference

13 December 2017

issue

8

1 reference

13 December 2017

page(s)

1064-1070

1 reference

Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma

13 December 2017

cites work

1 reference

Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival

21 January 2018

1 reference

How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?

21 January 2018

1 reference

Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma

21 January 2018

1 reference

Quantification of free circulating DNA as a diagnostic marker in lung cancer

21 January 2018

1 reference

Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma

21 January 2018

1 reference

Prognostic factors in metastatic nasopharyngeal carcinoma

21 January 2018

1 reference

Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up.

21 January 2018

1 reference

Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography

21 January 2018

1 reference

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type

21 January 2018

1 reference

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study.

21 January 2018

1 reference

Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma

21 January 2018

1 reference

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

21 January 2018

1 reference

7 January 2021

Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma

1 reference

7 January 2021

Locally recurrent nasopharyngeal carcinoma

1 reference

7 January 2021

Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma

1 reference

7 January 2021

The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients

1 reference

7 January 2021

Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival

1 reference

7 January 2021

Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma

1 reference

7 January 2021

Remarkable application of serum EBV EBER-1 in monitoring response of nasopharyngeal cancer patients to salvage chemotherapy

1 reference

7 January 2021

Retrospective case series of gemcitabine plus cisplatin in the treatment of recurrent and metastatic nasopharyngeal carcinoma

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.21890

1 reference

13 December 2017

1 reference